|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Vaccination with CD20 peptides induces a biologically active,specific immune response in mice显示文摘 | Roberts WK Livingston PO Agus DB | 2002 | Blood2002，99，10： | 1 |
| 2 | HER-2/neu as a therapeutic target in non-small cell lung cancer, prostate cancer, and ovarian cancer显示文摘 | AGUS DB BUNN PA JR FRANKLIN W | 2000 | Semin Oncol2000，27，611： | 1 |
| 3 | Detection of androgen receptor mutations in circulating tumor cells in castration-resistant prostate cancer 显示文摘 | Jiang Y Palma JF Agus DB | 2010 | Clin Chem2010，56，9： | 1 |
| 4 | Dehydroa scorbic acid, a blood brain barriertran sportable form of vitamin C, mediates potent cereb protection in experimental stroke 显示文摘 | Huang J Agus DB Winfree C J | 2001 | Proc Nail Acad Sci USA2001，98，11： | 1 |
| 5 | Targeting the HER-kinase axis in cancer显示文摘 | Gross ME Shazer RL Agus DB | 2004 | Sem in Oncol2004，31，13： | 1 |
| 6 | HER-2/neu as a therapeutic target in non-small cell lung cancer,prostate cancer,and ovarian cancer显示文摘 | Agus DB Bunn PA JR Franklin W | | 0，，06： | 1 |
| 7 | Targeting ligand-actibated ErbB2 singaling inhibits breast and prostate tumor growth 显示文摘 | Agus DB Akita RW Fox WD | 2002 | Cancer Cell2002，2，2： | 1 |
| 8 | Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R显示文摘 | AMLER LC AGUS DB LEDUC C | 2000 | Cancer Res2000，60，21： | 1 |
| 9 | HER2/neu as a therapeutic target in non-small cell lung cancer, postate cancer, and overian cancer显示文摘 | Agus DB Bum PA JR Franklin W | 2000 | Semin Oncol2000，27，： | 1 |
| 10 | Detection of androgen receptor mutations in circulating tumor cells in castration-resistant prostate cancer显示文摘 | Jiang Y Palma JF Agus DB | 2010 | Clin Chem2010，56，9： | 1 |
| 11 | Targeting the HER-kinase axis in cancer显示文摘 | Gross ME Shazer RL Agus DB | 2004 | Semin Oncol2004，31，3： | 1 |
| 12 | Prostate cancer cell cycle regulators: response to androgen withdrawal and development of androgen independence 显示文摘 | Agus DB Cordon-Cardo C Fox W | 1999 | J Natl Cancer Inst1999，91，21： | 1 |
| 13 | Phase I clinical study of pertuzurnab , a novel HER dimerization inhibitor, in patients with advanced cancer显示文摘 | Agus DB Gordon MS Taylor C | 2005 | J Clin Oncol2005，23，： | 1 |
| 14 | p21^WAF1/GIP1 gene is inactivated in metastatic prostatic cancer cell lines by promoter methylation 显示文摘 | Agus DB Cordon - Cardo C Fox W | 2005 | Prostate Cancer Prostatic Dis2005，8，4： | 1 |
| 15 | Safety, efficacy, and phar- macodynarnics of the investigational agent ortonel (TAK-700)in meta- static castration resistant prostate cancer (mCRPC):updated data from a phase 1 / II study显示文摘 | Agus DB Stadler WM Shevrin DH | 2012 | J Clin Oncol2012，30，5： | 1 |
| 16 | Detection of androgen receptor mutations in circulating tumor cells in castration- resistant prostate cancer显示文摘 | Jiang Y Palma JF Agus DB | 2010 | Clin Chem2010，56，9： | 1 |
| 17 | 查看详情显示文摘 | Butler LM Agus DB Scher HI | | 0，，18： | 1 |
| 18 | Prostate cancer cell cycle regulators:response to androgen withdrawal and development of androgen independence显示文摘 | Agus DB Cordon-Cardo C Fox W | 1999 | J Natl Cancer Inst1999，91，21： | 1 |
| 19 | HER-2/neu as a therapeutic target in non-small cell lung cancer,prostate cancer,and ovarian cancer显示文摘 | Agus DB Bunn PA Franklin W | 2000 | Semin Oncol2000，27，611： | 1 |
| 20 | Vitamin C crosses the blood brain barrier in the oxidized form through the glucose transporters显示文摘 | Agus DB Sanjiv SG Pardridge WM | 1997 | Journal of Clinical Investigation1997，100，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员